Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.

Mathsyaraja H, Thies K, Taffany DA, Deighan C, Liu T, Yu L, Fernandez SA, Shapiro C, Otero J, Timmers C, Lustberg MB, Chalmers J, Leone G, Ostrowski MC.

Oncogene. 2014 Sep 22. doi: 10.1038/onc.2014.294. [Epub ahead of print]

PMID:
25241894
[PubMed - as supplied by publisher]
2.

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Zhao M, Pan X, Layman R, Lustberg MB, Mrozek E, Macrae ER, Wesolowski R, Carothers S, Puhalla S, Shapiro CL, Ramaswamy B.

Invest New Drugs. 2014 Jun 5. [Epub ahead of print]

PMID:
24894652
[PubMed - as supplied by publisher]
3.

Treatment-related mortality with everolimus in cancer patients.

Wesolowski R, Abdel-Rasoul M, Lustberg M, Paskell M, Shapiro CL, Macrae ER.

Oncologist. 2014 Jun;19(6):661-8. doi: 10.1634/theoncologist.2013-0355. Epub 2014 May 2.

PMID:
24794158
[PubMed - in process]
4.

Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.

Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL.

Clin Breast Cancer. 2014 Aug;14(4):228-34. doi: 10.1016/j.clbc.2014.02.005. Epub 2014 Feb 20.

PMID:
24703985
[PubMed - in process]
Free PMC Article
5.

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ.

Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.

PMID:
24602188
[PubMed - in process]
Free PMC Article
6.

Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.

Wenzell CM, Berger MJ, Blazer MA, Crawford BS, Griffith NL, Wesolowski R, Lustberg MB, Phillips GS, Ramaswamy B, Mrozek E, Flynn JM, Shapiro CL, Layman RM.

Support Care Cancer. 2013 Oct;21(10):2845-51. doi: 10.1007/s00520-013-1865-9. Epub 2013 Jun 8.

PMID:
23748485
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Poi MJ, Berger M, Lustberg M, Layman R, Shapiro CL, Ramaswamy B, Mrozek E, Olson E, Wesolowski R.

Support Care Cancer. 2013 Oct;21(10):2679-86. doi: 10.1007/s00520-013-1842-3. Epub 2013 May 19.

PMID:
23686402
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors.

Aggarwal R, Lu J, Kanji S, Das M, Joseph M, Lustberg MB, Ray A, Pompili VJ, Shapiro CL, Das H.

Int J Cancer. 2013 Nov;133(9):2133-44. doi: 10.1002/ijc.28217. Epub 2013 May 29.

PMID:
23595559
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.

Layman RM, Ruppert AS, Lynn M, Mrozek E, Ramaswamy B, Lustberg MB, Wesolowski R, Ottman S, Carothers S, Bingman A, Reinbolt R, Kraut EH, Shapiro CL.

Cancer Chemother Pharmacol. 2013 May;71(5):1183-90. doi: 10.1007/s00280-013-2112-2. Epub 2013 Feb 21.

PMID:
23430121
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bone health in adult cancer survivorship.

Lustberg MB, Reinbolt RE, Shapiro CL.

J Clin Oncol. 2012 Oct 20;30(30):3665-74. doi: 10.1200/JCO.2012.42.2097. Epub 2012 Sep 24. Review.

PMID:
23008309
[PubMed - indexed for MEDLINE]
Free Article
11.

Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.

Yang X, Mrozek E, Lustberg M, Jia G, Sammet S, Sammet C, Shapiro C, Knopp MV.

Magn Reson Imaging. 2012 Oct;30(8):1059-67. doi: 10.1016/j.mri.2012.04.026. Epub 2012 Aug 11.

PMID:
22884756
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.

Lustberg MB, Pant S, Ruppert AS, Shen T, Wei Y, Chen L, Brenner L, Shiels D, Jensen RR, Berger M, Mrozek E, Ramaswamy B, Grever M, Au JL, Wientjes MG, Shapiro CL.

Cancer Chemother Pharmacol. 2012 Jul;70(1):49-56. doi: 10.1007/s00280-012-1887-x. Epub 2012 May 22.

PMID:
22729159
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Pneumocystis jiroveci Pneumonia in an Atypical Host.

Reinbolt RE, Alam S, Layman R, Shapiro C, Lustberg M.

Clin Breast Cancer. 2012 Apr;12(2):138-41. doi: 10.1016/j.clbc.2011.10.003. Epub 2011 Dec 1. No abstract available.

PMID:
22133356
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.

Berger MJ, Dunlea LJ, Rettig AE, Lustberg MB, Phillips GS, Shapiro CL.

Support Care Cancer. 2012 Sep;20(9):1991-7. doi: 10.1007/s00520-011-1303-9. Epub 2011 Nov 17.

PMID:
22089428
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer.

Lustberg MB, Povoski SP, Zhao W, Ziegler RM, Sugimoto Y, Ruppert AS, Lehman AM, Shiels DR, Mrozek E, Ramaswamy B, Layman RM, Brueggemeier RW, Shapiro CL.

Clin Breast Cancer. 2011 Aug;11(4):221-7. doi: 10.1016/j.clbc.2011.03.022. Epub 2011 May 19.

PMID:
21729671
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk